DETERMINATION OF FREQUENCY AND RISK FACTORS OF SECONDARY MALIGNANCY DEVELOPMENT IN HEMATOLOGICAL MALIGNANCIES
Objective: Cancer remains a significant challenge within the healthcare system. According to the 2022 GLOBOCAN report, approximately 20 million people were diagnosed with cancer, and 10 million people passed away due to the disease. A significant improvement in the prevention, diagnosis, and treatme...
Saved in:
| Main Authors: | Ennur Ramadan, Güven Çetin, Özge Pasin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924028621 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PERITONEAL MESOTHELIOMA AS A CO-MALIGNANCY IN A PATIENT WITH CLL/SLL: CASE REPORT
by: Satı Betül Beydilli, et al.
Published: (2024-12-01) -
Secondary infections after cytotoxic chemotherapy in patient with hematological malignancies
by: Seyit Ali Büyüktuna, et al.
Published: (2017-07-01) -
Impact of secondary hematologic malignancies on prognosis of Hodgkin’s lymphoma survivors
by: Fangheng Lin, et al.
Published: (2025-05-01) -
Lymphoid hematological malignancies
by: D. A. Domninskiy
Published: (2014-07-01) -
Myeloid hematological malignancies
by: D. A. Domninsky
Published: (2014-07-01)